Surgeons at Children’s Hospital Los Angeles treat the hospital’s first patient with gene therapy
CHLA has established itself as a leader in the field by having one of the largest pediatric diaphragm pacer programs in the world and one of the largest home mechanical ventilation programs in the world.
Researchers determine that the U.S. Healthcare System is not prepared for a surge in pediatric patients after an infectious disease pandemic. The study was published in the American Journal of Disaster Medicine.
Before Angelique Garcia was born, doctors at Children’s Hospital Los Angeles (CHLA) knew she had a severe form of congenital heart disease called complete atrioventricular canal defect (CAVC).
Three top doctors from Children’s Hospital Los Angeles (CHLA) have been accepted into the American Pediatric Society (APS) – a distinguished membership of leaders in academic pediatrics.
Children’s Hospital Los Angeles has announced participation in the first-ever clinical trial using stem cells from umbilical cord blood to delay or even prevent heart failure in children born with a rare congenital heart defect, called hypoplastic left…
Affirming his ongoing commitment to protect children’s health and the role of children’s hospitals in medical care, Children’s Hospital Los Angeles President and CEO Paul S. Viviano has been elected chair of the California Children’s Hospital Associati…
Results of the global, multicenter, pivotal phase 2 study that led to the first FDA approval of a gene therapy/cell therapy approach known as CAR T-cell therapy, were published today in the New England Journal of Medicine.
2-year-old Children’s Hospital Los Angeles patient Pierce Kelly beats leukemia thanks to a stem cell donor in France and inspires thousands of potential donors.
Children’s Hospital Los Angeles is the largest craniofacial program for children in the country and is directed by Mark Urata, MD, DDS, chief of Plastic and Reconstructive Surgery at CHLA. He comments on Treacher Collins Syndrome and other facial diffe…